Oracle and Ci4CC Partner to Accelerate Oncology Innovation
Go back to Oracle and Ci4CC Partner to Accelerate Oncology Innovation| Oracle Corp. (NYSE: ORCL) | Delayed: 142.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $142.45 | 52 Week High | $42.00 | |||
| Open | $142.45 | 52 Week Low | $33.13 | |||
| Day High | $142.45 | P/E | 60.88 | |||
| Day Low | $142.45 | EPS | $2.34 | |||
| Volume | 59,369 | |||||

